The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[4-[(1-bromo-2-naphthyl)oxy]-3-chloro-phenyl]-3-hydroxy-4-methyl-benzamide ID: ALA4783506
PubChem CID: 162665855
Max Phase: Preclinical
Molecular Formula: C24H17BrClNO3
Molecular Weight: 482.76
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C(=O)Nc2ccc(Oc3ccc4ccccc4c3Br)c(Cl)c2)cc1O
Standard InChI: InChI=1S/C24H17BrClNO3/c1-14-6-7-16(12-20(14)28)24(29)27-17-9-11-21(19(26)13-17)30-22-10-8-15-4-2-3-5-18(15)23(22)25/h2-13,28H,1H3,(H,27,29)
Standard InChI Key: DISFEAHZBPETIJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
29.3737 -4.8338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0820 -4.4188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0772 -3.5926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3681 -3.1892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7954 -4.8288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.5056 -4.4133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2162 -4.8277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9260 -4.4129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9233 -3.5907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2049 -3.1851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4980 -3.5981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2166 -5.6490 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.6329 -3.1785 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3469 -3.5834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0566 -3.1711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3512 -4.4047 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.7649 -3.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4741 -3.1665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4702 -2.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7513 -1.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0492 -2.3536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6582 -4.4206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6636 -3.6018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9611 -3.1899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2487 -3.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2433 -4.4112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9503 -4.8276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3762 -5.6510 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
37.1832 -3.5727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.1757 -1.9318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 23 1 0
2 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
7 12 1 0
9 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 15 1 0
22 23 2 0
22 27 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
1 28 1 0
18 29 1 0
19 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 482.76Molecular Weight (Monoisotopic): 481.0080AlogP: 7.31#Rotatable Bonds: 4Polar Surface Area: 58.56Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.15CX Basic pKa: ┄CX LogP: 7.14CX LogD: 7.13Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.32Np Likeness Score: -0.90
References 1. Fujii S,Kikuchi E,Watanabe Y,Suzuyama H,Ishigami-Yuasa M,Mori T,Isobe K,Uchida S,Kagechika H. (2020) Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling., 30 (17): [PMID:32738993 ] [10.1016/j.bmcl.2020.127408 ]